Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel S Merseburger

Showing results (131-140 of 323) with videos related to

Pageof 33
Sort By:
Oncology Letters|December 19, 2017
Rho GDP dissociation inhibitor-β in renal cell carcinomaChristoph-Alexander von Klot, Natalia Dubrowinskaja, Inga Peters, et al.
European Urology|May 1, 2020
The Impact of COVID-19 Outbreak on Uro-oncological Practice Across Europe: Which Burden of Activity Are We Facing Ahead?Marco Oderda, Morgan Roupret, Giancarlo Marra, et al.
Indian Journal of Urology : IJU : Journal of the Urological Society of India|May 27, 2009
Surgical approach in patients with T4 bladder cancer as primary treatment: Disaster or option with improved quality of lifeUdo Nagele, Aristotelis G Anastasiadis, Axel S Merseburger, et al.
Oncology Reports|April 8, 2010
Altered expression of Akt signaling pathway parameters in prostate needle biopsies derived from benign, adjacent and cancerous tissueSandra Waalkes, Perikles Simon, Jörg Hennenlotter, et al.
BJU International|October 11, 2011
High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinomaStephan Kruck, Axel S Merseburger, Joerg Hennenlotter, et al.
World Journal of Urology|August 16, 2012
Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrenceJudith S Knapp, Soum D Lokeshwar, Ulrich Vogel, et al.
Nature Reviews. Urology|June 3, 2015
Developing proteomic biomarkers for bladder cancer: towards clinical applicationMaria Frantzi, Agnieszka Latosinska, Leif Flühe, et al.
European Urology Open Science|June 17, 2025
Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate CancerMike Wenzel, Thomas Steuber, Carolin Siech, et al.
Rare Tumors|February 2, 2013
Clear-cell variant urothelial carcinoma of the bladder: a case report and review of the literatureMario W Kramer, Mahmoud Abbas, Stefanie Pertschy, et al.
European Urology Focus|July 30, 2017
Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder CancerMario W Kramer, Vincenzo Altieri, Rodolfo Hurle, et al.
Pageof 33

Showing results (131-140 of 323) with videos related to

Sort By:
Pageof 33
Oncology Letters|December 19, 2017
Rho GDP dissociation inhibitor-β in renal cell carcinomaChristoph-Alexander von Klot, Natalia Dubrowinskaja, Inga Peters, et al.
European Urology|May 1, 2020
The Impact of COVID-19 Outbreak on Uro-oncological Practice Across Europe: Which Burden of Activity Are We Facing Ahead?Marco Oderda, Morgan Roupret, Giancarlo Marra, et al.
Indian Journal of Urology : IJU : Journal of the Urological Society of India|May 27, 2009
Surgical approach in patients with T4 bladder cancer as primary treatment: Disaster or option with improved quality of lifeUdo Nagele, Aristotelis G Anastasiadis, Axel S Merseburger, et al.
Oncology Reports|April 8, 2010
Altered expression of Akt signaling pathway parameters in prostate needle biopsies derived from benign, adjacent and cancerous tissueSandra Waalkes, Perikles Simon, Jörg Hennenlotter, et al.
BJU International|October 11, 2011
High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinomaStephan Kruck, Axel S Merseburger, Joerg Hennenlotter, et al.
World Journal of Urology|August 16, 2012
Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrenceJudith S Knapp, Soum D Lokeshwar, Ulrich Vogel, et al.
Nature Reviews. Urology|June 3, 2015
Developing proteomic biomarkers for bladder cancer: towards clinical applicationMaria Frantzi, Agnieszka Latosinska, Leif Flühe, et al.
European Urology Open Science|June 17, 2025
Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate CancerMike Wenzel, Thomas Steuber, Carolin Siech, et al.
Rare Tumors|February 2, 2013
Clear-cell variant urothelial carcinoma of the bladder: a case report and review of the literatureMario W Kramer, Mahmoud Abbas, Stefanie Pertschy, et al.
European Urology Focus|July 30, 2017
Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder CancerMario W Kramer, Vincenzo Altieri, Rodolfo Hurle, et al.
Pageof 33